Abstract
The isotope 157Gd has been evaluated at the University of Missouri- Columbia (MU) as an alternative neutron capture therapy (NCT) agent to 10B The studies were directed to the following three major portions: the evaluation of Gd Neutron Capture Therapy (GdNCT), the combination of NCT and brachytherapy and the development of neutron autoradiography for Gd.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
J.A. Shih, “Gadolinium as a Neutron Capture Therapy Agent”, PhD dissertation, University of Missouri-Columbia May 1991
R.M. Brugger and J.A. Shih, “Evaluation of 157Gd as a Neutron Capture Therapy Agent”, Strahlentherapie und Onkologie, Proceedings of the 3rd International Symposium on Neutron Capture Therapy, Bremen, FRG, 1988, Urban and Vogel, FRG, 1989
R.F. Martin, G. d’Cunha, M. Pardee, and B.J. Allen, “Induction of Double-Strand Breaks Following Neutron Capture by DNA-Bound Gd-157”, Int. J. Rad. Biol. Phys. Chem. Med., accepted 1987
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shih, J.A., Brugger, R.M. (1992). Gadolinium as a Neutron Capture Therapy Agent. In: Allen, B.J., Moore, D.E., Harrington, B.V. (eds) Progress in Neutron Capture Therapy for Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3384-9_37
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3384-9_37
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6494-8
Online ISBN: 978-1-4615-3384-9
eBook Packages: Springer Book Archive